Radiogenomics of magnetic resonance imaging and a new multi-gene classifier for predicting recurrence prognosis in estrogen receptor-positive breast cancer-Reference-Cited by-同舟云学术

Radiogenomics of magnetic resonance imaging and a new multi-gene classifier for predicting recurrence prognosis in estrogen receptor-positive breast cancer

Published:2020-04 Issue:16 Volume:99 Page:e19664
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Tokuda Yukiko,Yanagawa Masahiro,Minamitani Kaori,Naoi Yasuto,Noguchi Shinzaburo,Tomiyama Noriyuki

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference40 articles.

1. Development of the 21-gene assay and its application in clinical practice and clinical trials;Sparano;J Clin Oncol,2008

2. Multi-field-of-view strategy for image-based outcome prediction of multi-parametric estrogen receptor-positive breast cancer histopathology: comparison to Oncotype DX;Basavanhally;J Pathol Inform,2011

3. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer;Paik;N Engl J Med,2004

4. Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer;Paik;J Clin Oncol,2006

5. Development of 95-gene classifier as a powerful predictor of recurrences in node negative and ER-positive breast cancer patients;Naoi;Breast Cancer Res Treat,2011

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Artificial intelligence in breast imaging: potentials and challenges;Physics in Medicine & Biology;2023-11-28

2. The use of radiomics in magnetic resonance imaging for the pre‐treatment characterisation of breast cancers: A scoping review;Journal of Medical Radiation Sciences;2023-08-03

3. Artificial Intelligence in Breast Imaging;Holistic Approach to Breast Disease;2023

4. Multi-gene assay 95- and 155-gene classifiers for prognosis prediction and chemotherapy omission in lymphnode positive luminal-type breast cancer;Cancer Treatment and Research Communications;2023

5. Artificial Intelligence—Enhanced Breast MRI and DWI: Current Status and Future Applications;Diffusion MRI of the Breast;2023